Literature DB >> 29671191

Rheumatoid arthritis is associated with increased in-hospital mortality in asthma exacerbations: a nationwide study.

Yiming Luo1, Xiaowen Fan2, Changchuan Jiang2, Ana Belen Arevalo Molina2, Maria Salgado3, Jiehui Xu4.   

Abstract

The relationship between RA and asthma has been yielding conflicting results, with most recent studies showing a possible positive association. The study aims at the outcomes of adult patients hospitalized for asthma exacerbation in those with and without RA. We used data from the National Inpatient Sample (NIS) for the period of 2012-2014. ICD 9 code was used to identify the diagnosis. Our primary outcome was in-hospital mortality. Our secondary outcome was total asthma exacerbation hospitalizations, length of stay, and total hospital charges. Compared to those without RA, RA was associated with increased hospitalizations for asthma exacerbation (unadjusted OR 1.29, p < 0.001; adjusted OR 1.06, p = 0.002), more respiratory and systemic comorbidities, increased in-hospital mortality (unadjusted OR 1.89, p = 0.001; adjusted OR 1.60, p = 0.020), length of stay (4.5 vs 3.8; unadjusted p < 0.001, adjusted p < 0.001), and total hospital charges (30,149 vs 26,247; unadjusted p < 0.001, adjusted p = 0.048). Our study was the first to demonstrate that RA is associated with increased in-hospital mortality, length of stay, and cost using a national inpatient database. We hypothesize that in asthmatic patients with concurrent RA, their asthma may represent a distinctive subgroup that is more severe and carries a poorer prognosis, which deserves more attention and future investigation.

Entities:  

Keywords:  Asthma; Cross-sectional study; Mortality; Rheumatoid arthritis

Mesh:

Year:  2018        PMID: 29671191     DOI: 10.1007/s10067-018-4114-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  21 in total

1.  Characterization of a high TNF-α phenotype in children with moderate-to-severe asthma.

Authors:  Sheena D Brown; Lou Ann Brown; Susan Stephenson; Jennifer C Dodds; Shaneka L Douglas; Hongyan Qu; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol       Date:  2015-02-26       Impact factor: 10.793

Review 2.  Lung disease in rheumatoid arthritis.

Authors:  Zulma X Yunt; Joshua J Solomon
Journal:  Rheum Dis Clin North Am       Date:  2015-02-03       Impact factor: 2.670

3.  Atopic disorders in ankylosing spondylitis and rheumatoid arthritis.

Authors:  M Rudwaleit; B Andermann; R Alten; H Sörensen; J Listing; A Zink; J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 4.  TNF as a Target of Inflammation in Rheumatoid Arthritis.

Authors:  Hisashi Yamanaka
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2015       Impact factor: 2.895

5.  A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma.

Authors:  Sally E Wenzel; Peter J Barnes; Eugene R Bleecker; Jean Bousquet; William Busse; Sven-Erik Dahlén; Stephen T Holgate; Deborah A Meyers; Klaus F Rabe; Adam Antczak; James Baker; Ildiko Horvath; Zsuzsanna Mark; David Bernstein; Edward Kerwin; Rozsa Schlenker-Herceg; Kim Hung Lo; Rosemary Watt; Elliot S Barnathan; Pascal Chanez
Journal:  Am J Respir Crit Care Med       Date:  2009-01-08       Impact factor: 21.405

6.  The role of a soluble TNFalpha receptor fusion protein (etanercept) in corticosteroid refractory asthma: a double blind, randomised, placebo controlled trial.

Authors:  J B Morjaria; A J Chauhan; K S Babu; R Polosa; D E Davies; S T Holgate
Journal:  Thorax       Date:  2008-02-01       Impact factor: 9.139

Review 7.  Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of Asthma.

Authors:  Mary Claire Rolfes; Young Jun Juhn; Chung-Il Wi; Youn Ho Sheen
Journal:  Tuberc Respir Dis (Seoul)       Date:  2017-03-31

Review 8.  Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype.

Authors:  R H Dougherty; J V Fahy
Journal:  Clin Exp Allergy       Date:  2009-02       Impact factor: 5.018

9.  Diagnosis and management of asthma - Statement on the 2015 GINA Guidelines.

Authors:  Fritz Horak; Daniel Doberer; Ernst Eber; Elisabeth Horak; Wolfgang Pohl; Josef Riedler; Zsolt Szépfalusi; Felix Wantke; Angela Zacharasiewicz; Michael Studnicka
Journal:  Wien Klin Wochenschr       Date:  2016-07-01       Impact factor: 1.704

Review 10.  Asthma.

Authors:  Stephen T Holgate; Sally Wenzel; Dirkje S Postma; Scott T Weiss; Harald Renz; Peter D Sly
Journal:  Nat Rev Dis Primers       Date:  2015-09-10       Impact factor: 52.329

View more
  2 in total

1.  Adding Chinese Herbal Medicine to Routine Care is Associated With a Lower Risk of Rheumatoid Arthritis Among Patients With Asthma: A Population-Based Retrospective Cohort Study.

Authors:  Wei-Chiao Chang; Hanoch Livneh; Wei-Jen Chen; Chang-Cheng Hsieh; Yu-Han Wang; Ming-Chi Lu; How-Ran Guo; Tzung-Yi Tsai
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

2.  Elevated Anti-Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma.

Authors:  Alessandra Zaccardelli; Xinyi Liu; Julia A Ford; Jing Cui; Bing Lu; Su H Chu; Peter H Schur; Cameron B Speyer; Karen H Costenbader; William H Robinson; Jeremy Sokolove; Elizabeth W Karlson; Carlos A Camargo; Jeffrey A Sparks
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-04       Impact factor: 4.794

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.